You have 9 free searches left this month | for more free features.

Antibodies, monoclonal

Showing 7051 - 7075 of 7,894

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lymphoma Trial in United Kingdom (biological, dietary supplement, drug, other)

Withdrawn
  • Lymphoma
  • filgrastim
  • +7 more
  • London, England, United Kingdom
  • +4 more
Aug 23, 2013

Smallpox Trial in Lenexa, Lexington (ACAM3000 MVA Vaccine)

Completed
  • Smallpox
  • ACAM3000 MVA Vaccine
  • Lenexa, Kansas
  • +1 more
Jan 9, 2014

Lymphoma, Small Intestine Cancer Trial in Stanford (visilizumab)

Completed
  • Lymphoma
  • Small Intestine Cancer
  • visilizumab
  • Stanford, California
    Stanford University Medical Center
May 14, 2013

Colorectal Cancer Trial in United States (trastuzumab, irinotecan HCl)

Completed
  • Colorectal Cancer
  • trastuzumab
  • irinotecan hydrochloride
  • Bronx, New York
  • +4 more
Feb 7, 2013

Acute Gout Trial in Worldwide (Canakinumab 150 mg, Triamcinolone acetonide 40 mg, Placebo to canakinumab)

Completed
  • Acute Gout
  • Canakinumab 150 mg
  • +3 more
  • Darlinghurst, New South Wales, Australia
  • +46 more
Dec 24, 2013

Lymphoma Trial in Stanford (apolizumab)

Completed
  • Lymphoma
  • apolizumab
  • Stanford, California
    Stanford University Medical Center
May 14, 2013

Carcinoma, Squamous Cell, Carcinoma, Adenosquamous, Carcinoma, Large Cell Trial in Worldwide (CP-751,871 (Figitumumab),

Terminated
  • Carcinoma, Squamous Cell
  • +3 more
  • CP-751,871 (Figitumumab)
  • +2 more
  • Florence, Alabama
  • +279 more
Dec 11, 2013

Head Neck Cancer Trial in New York (biological, drug, radiation)

Completed
  • Head and Neck Cancer
  • cetuximab
  • +2 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 17, 2013

Hepatitis C, Liver Transplantation Trial in Worldwide (Tacrolimus, steroids, monoclonal anti-IL2R antibody)

Completed
  • Hepatitis C
  • Liver Transplantation
  • Praha, Czech Republic
  • +16 more
Apr 9, 2013

Leukemia, Lymphoma Trial in Philadelphia (rituximab, epirubicin HCl)

Completed
  • Leukemia
  • Lymphoma
  • rituximab
  • epirubicin hydrochloride
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Jul 10, 2013

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in New York (abagovomab)

Completed
  • Fallopian Tube Cancer
  • +2 more
  • abagovomab
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 4, 2013

Breast Cancer Trial in Italy (biological, drug, procedure, radiation)

Unknown status
  • Breast Cancer
  • trastuzumab
  • +11 more
  • Cuneo, Italy
  • +5 more
Aug 6, 2013

Colorectal Cancer Trial in Los Angeles (Bevacizumab, Capecitabine, 5-Fluorouracil (5-FU))

Completed
  • Colorectal Cancer
  • Bevacizumab
  • +4 more
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center at UCLA
Jun 19, 2013

B-cell Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia Trial in Columbus

Terminated
  • B-cell Chronic Lymphocytic Leukemia
  • +2 more
  • Columbus, Ohio
    Ohio State University Medical Center
Jun 3, 2013

Melanoma Trial in Nashville (biological, drug, genetic, other, procedure)

Completed
  • Melanoma
  • bevacizumab
  • +6 more
  • Nashville, Tennessee
  • +3 more
Jul 15, 2013

Breast Cancer Trial in United States (biological, drug, procedure, radiation)

Completed
  • Breast Cancer
  • bevacizumab
  • +7 more
  • Cleveland, Ohio
  • +4 more
Jun 14, 2013

Breast Cancer Trial in New York (trastuzumab, pegylated liposomal doxorubicin HCl)

Completed
  • Breast Cancer
  • trastuzumab
  • pegylated liposomal doxorubicin hydrochloride
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 18, 2013

Diphtheria, Pertussis, Tetanus Trial in Muntinlupa City (Quinvaxem, Quinvaxem/Tritanrix)

Completed
  • Diphtheria
  • +4 more
  • Quinvaxem
  • Quinvaxem/Tritanrix
  • Muntinlupa City, Philippines
    Research Institute for Tropical Medicine
Aug 29, 2013

Acute Gout Trial in Worldwide (Canakinumab 150 mg, Triamcinolone acetonide 40 mg, Placebo to canakinumab)

Completed
  • Acute Gout
  • Canakinumab 150 mg
  • +3 more
  • Anniston, Alabama
  • +107 more
Dec 24, 2013

Sarcoma Trial (trastuzumab)

Completed
  • Sarcoma
  • trastuzumab
  • (no location specified)
Jun 21, 2013

Breast Cancer Trial in Japan (trastuzumab, capecitabine)

Completed
  • Breast Cancer
  • Fukuoka, Japan
  • +9 more
Jul 9, 2013

Undifferentiated Arthritis Trial in Bruxelles (Infliximab, sodium chloride)

Completed
  • Undifferentiated Arthritis
  • Bruxelles, Belgium
    Université Catholique de Louvain
Oct 30, 2013

Lymphoma Trial in United States (autologous immunoglobulin idiotype-KLH conjugate vaccine, rituximab, sargramostim)

Terminated
  • Lymphoma
  • autologous immunoglobulin idiotype-KLH conjugate vaccine
  • +2 more
  • Birmingham, Alabama
  • +59 more
Aug 1, 2013

Leukemia Trial in United Kingdom (rituximab, cyclophosphamide, fludarabine phosphate)

Completed
  • Leukemia
  • rituximab
  • +3 more
  • Birmingham, England, United Kingdom
  • +15 more
Aug 1, 2013

Lymphoma Trial (biological, drug, genetic, other)

Unknown status
  • Lymphoma
  • rituximab
  • +10 more
  • (no location specified)
Aug 1, 2013